NYSE:INO
Inovio Pharmaceuticals Stock News
$12.00
-0.790 (-6.18%)
At Close: May 17, 2024
Inovio Coronavirus Vaccine Study Shows Months Of Immunity In Primates, Sending Stock Higher
10:34am, Thursday, 30'th Jul 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were moving to the upside Thursday after slipping 6.3% in the prior session.
Inovio Coronavirus Vaccine Study Shows Months Of Immunity In Primates, Sending Stock Higher
12:00am, Thursday, 30'th Jul 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were moving to the upside Thursday after slipping 6.3% in the prior session.
What Happened: Plymouth, Pennsylvania-based...
Wednesday’s Midday Movers: Celldex (CLDX), Cameco (CCJ), TG Therapeutics (TGTX), Dynavax (DVAX), Inovio Pharmaceuticals (INO) - Markets
05:48pm, Wednesday, 29'th Jul 2020
So far Wednesday, July 29, NASDAQ is up 1.03% and the S&P is up 1.94%. Let’s take a look at
Inovio's Drug For Rare Respiratory Tract Disorder Granted Orphan Designation
10:33am, Wednesday, 29'th Jul 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were volatile Wednesday after the company announced Orphan Drug Designation for one of its pipeline drugs.
Got $10,000? Invest in These 3 Coronavirus Vaccine Stocks
09:13am, Wednesday, 29'th Jul 2020
These three stocks are exposed to big upsides from vaccine development, but they're also rich with research collaborations and government funding.
Whatever Happens to Inovio Pharmaceuticals, Insiders Will Do Just Fine
07:55am, Wednesday, 29'th Jul 2020
Inovio Pharmaceuticals' (NASDAQ:INO) insiders are benefitting from the novel coronavirus and the rise of INO stock.
The post Whatever Happens to Inovio Pharmaceuticals, Insiders Will Do Just Fine app
PLYMOUTH MEETING, Pa., July 29, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO) today announced that the U.S.
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
Better Coronavirus Stock: Inovio vs. Vaxart
07:02am, Tuesday, 28'th Jul 2020
Two biotechs with promising COVID-19 vaccine candidates. But one is the clear winner right now.
So far Monday, July 27, NASDAQ is up 2.28% and the S&P is up 0.89%. Here are this morning’s most
Inovio Is Too Risky for the Average Investor
01:08pm, Monday, 27'th Jul 2020
With the likelihood of a coronavirus vaccine still largely unknown, betting on INO stock based on its vaccine candidate is too risky.
The post Inovio Is Too Risky for the Average Investor appeared fir
Here's Your Guide to the Coronavirus Vaccine Leaders
02:33pm, Sunday, 26'th Jul 2020
Let's take a look at what's happened so far and what's on the horizon.
Should Inovio Pharmaceuticals Be Your Next Coronavirus Buy?
08:08am, Saturday, 25'th Jul 2020
Inovio is making headlines with its coronavirus vaccine candidate. Investors have been reaping the rewards.
Why Moderna, Vaxart, Inovio, and BioNTech Stocks Dropped Today
07:31pm, Friday, 24'th Jul 2020
COVID-19 vaccines might not be the moneymakers investors are hoping for.
The Further It Lags in the Vaccine Race, the Riskier Inovio Stock Looks
08:49am, Friday, 24'th Jul 2020
Inovio Pharmaceuticals (NASDAQ:INO) is a contender in the hyper-competitive field to develop a novel coronavirus vaccine, but with the company falling behind rivals, INO stock is risky. Source: Ascann
